\-\ Texto\\:\\ \ \(0\)\
\-\ musculoskeletal\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ adequately\\ aligned\\ spine\\.\\ diffuse\\ joint\\ tenderness\\;\\ no\\ joint\\ erythema\\.\\ normal\\ muscular\\ development\\.\\ normal\\ gait\\.\ \(0\)\
\-\ \\â\\€\\¢\\ range\\ of\\ motion\\:\ \(0\)\
\-\ \\Â\\»\\ limited\\ cervical\\ extension\\ \\(67\\%\\ of\\ normal\\)\\,\\ r\\ and\\ l\\ lateral\\ cervical\\ bending\\ \\(45\\%\\ and\\ 64\\%\\ of\\ normal\\)\\ \\[1\\]\\.\ \(0\)\
\-\ \\Â\\»\\ cervical\\ flexion\\,\\ extension\\,\\ rotation\\ elicits\\ pain\\ in\\ the\\ back\\ of\\ the\\ neck\\ that\\ radiates\\ to\\ shoulder\\.\ \(0\)\
\-\ \\Â\\»\\ limited\\ lumbar\\ flexion\\ \\(85\\%\\ of\\ normal\\)\\ and\\ extension\\ \\(60\\%\\ of\\ normal\\)\\ \\[1\\]\\.\ \(0\)\
\-\ \\Â\\»\\ limited\\ lumbar\\ r\\ and\\ l\\ lateral\\ bending\\ \\(68\\%\\ and\\ 84\\%\\ of\\ normal\\)\\ \\[1\\]\\.\ \(0\)\
\-\ \\Â\\»\\ lumbar\\ flexion\\ elicits\\ pain\\ in\\ low\\ back\\,\\ both\\ buttocks\\ and\\ thighs\\ down\\ to\\ knees\\.\ \(0\)\
\-\ \\Â\\»\\ lumbar\\ extension\\ elicits\\ pain\\ in\\ low\\ back\\;\\ denies\\ radiation\\.\ \(0\)\
\-\ \\Â\\»\\ normal\\ rom\\ in\\ r\\ and\\ l\\ straight\\ leg\\ raise\\.\ \(0\)\
\-\ \\Â\\»\\ r\\ leg\\ raise\\ elicits\\ pain\\ in\\ low\\ back\\,\\ r\\ buttock\\,\\ and\\ r\\ thigh\\.\ \(0\)\
\-\ \\Â\\»\\ l\\ leg\\ raise\\ elicits\\ pain\\ in\\ low\\ back\\,\\ l\\ buttock\\,\\ and\\ l\\ thigh\\.\ \(0\)\
\-\ \\â\\€\\¢\\ algometer\\ study\\,\\ as\\ done\\ per\\ protocol\\,\\ elicited\\ increased\\ sensitivity\\ to\\ pain\\ bilaterally\\ at\\:\\ suboccipital\\ muscle\\ insertions\\;\\ midpoint\\ of\\ upper\\ border\\ of\\ trapezius\\ muscle\\;\\ supraspinatus\\ muscle\\ above\\ the\\ scapula\\ spines\\;\\ second\\ costochondral\\ junctions\\;\\ 2\\ centimeters\\ distal\\ to\\ lateral\\ epicondyles\\ of\\ the\\ elbows\\;\\ upper\\ outer\\ quadrants\\ of\\ buttocks\\;\\ piriformis\\ insertion\\;\\ medial\\ aspect\\ of\\ knees\\.\\ no\\ increased\\ pain\\ sensitivity\\ at\\ the\\ anterior\\ aspects\\ of\\ inter\\-transverse\\ spaces\\ between\\ c5\\ and\\ c7\\.\ \(0\)\
\-\ neurological\\:\ \(0\)\
\-\ \\â\\€\\¢\\ monofilament\\ sensory\\ testing\\:\\ \ \(0\)\
\-\ \\Â\\»\\ diminished\\ light\\ touch\\ in\\ dorsal\\ surface\\ of\\ distal\\ r\\ forearm\\.\ \(0\)\
\-\ \\Â\\»\\ diminished\\ light\\ touch\\ in\\ plantar\\ surface\\ of\\ l\\ 5th\\ toe\\ and\\ distal\\ lateral\\ plantar\\ surface\\ of\\ l\\ foot\\.\ \(0\)\
\-\ \\â\\€\\¢\\ straight\\ leg\\ test\\:\\ positive\\ for\\ both\\ legs\\.\ \(0\)\
\-\ \\â\\€\\¢\\ motor\\:\\ \ \(0\)\
\-\ \\Â\\»\\ shoulder\\ abduction\\-\\ 5\\/5\\ on\\ right\\;\\ 5\\/5\\ on\\ left\ \(0\)\
\-\ \\Â\\»\\ elbow\\ flexion\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 4\\/5\\ on\\ left\\;\\ 26\\.1\\%\\ deficit\\ on\\ the\\ l\\ \\[1\\]\ \(0\)\
\-\ \\Â\\»\\ elbow\\ extension\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 5\\/5\\ on\\ left\ \(0\)\
\-\ \\Â\\»\\ hip\\ flexion\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 4\\/5\\ on\\ left\\;\\ 19\\.7\\%\\ deficit\\ on\\ the\\ l\\ \\[1\\]\ \(0\)\
\-\ \\Â\\»\\ hip\\ extension\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 4\\/5\\ on\\ left\\;\\ 26\\.7\\%\\ deficit\\ on\\ the\\ l\\ \\[1\\]\ \(0\)\
\-\ \\Â\\»\\ hallux\\ flexion\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 5\\/5\\ on\\ left\ \(0\)\
\-\ \\Â\\»\\ hallux\\ extension\\ \\â\\€\\“\\ 5\\/5\\ on\\ right\\;\\ 5\\/5\\ on\\ left\ \(0\)\
\-\ \\â\\€\\¢\\ jamar\\ grip\\ dynamometer\\:\\ r\\ 60lbs\\;\\ l\\ 55lbs\\;\\ r\\-handed\\.\ \(0\)\
\-\ \\â\\€\\¢\\ cranial\\ nerves\\:\\ ii\\-xii\\ intact\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ deep\\ tendon\\ reflexes\\:\\ \\+2\\ at\\ brachioradialis\\,\\ biceps\\,\\ triceps\\,\\ patellar\\,\\ and\\ achilles\\ bilaterally\\.\ \(0\)\
\-\ \\â\\€\\¢\\ skin\\:\\ diffuse\\ abnormal\\ pigmentation\\,\\ especially\\ on\\ the\\ upper\\ extremities\\,\\ chest\\,\\ upper\\ back\\,\\ abdomen\\.\\ no\\ lesions\\ or\\ eruptions\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ cocchiarella\\ l\\,\\ andersson\\ gbj\\.\\ guidelines\\ to\\ the\\ evaluation\\ of\\ permanent\\ impairment\\ \\(5e\\)\\.\\ chicago\\:\\ ama\\ press\\;\\ 2001\\.\ \(0\)\
\-\ the\\ patient\\ continues\\ to\\ receive\\ thorough\\ chiropractic\\ care\\ to\\ the\\ cervical\\ and\\ lumbar\\ spine\\,\\ and\\ upper\\ and\\ lower\\ extremities\\ for\\ symptomatic\\ relief\\ of\\ his\\ arthralgia\\.\\ the\\ patient\\ was\\ instructed\\ to\\ take\\ over\\-the\\-counter\\ doses\\ of\\ acetaminophen\\ as\\ needed\\ to\\ alleviate\\ diffuse\\ pain\\,\\ as\\ well\\ as\\ lifestyle\\ modifications\\ involving\\ improved\\ diet\\ and\\ exercise\\.\\ \\ further\\ evaluation\\ is\\ needed\\,\\ with\\ possible\\ administration\\ of\\ tri\\-cyclic\\ antidepressants\\ \\(amitriptyline\\ or\\ cyclobenzaprine\\)\\,\\ serotonin\\-norepinephrine\\ reuptake\\ inhibitors\\ \\(duloxetine\\ or\\ milnacipran\\)\\,\\ or\\ gabapentinoids\\ \\(pregabalin\\,\\ gabapentin\\)\\ \\ if\\ a\\ diagnosis\\ of\\ fibromyalgia\\ is\\ confirmed\\ \\[1\\]\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ schmidt\\-wilcke\\ t\\,\\ clauw\\ dj\\.\\ fibromyalgia\\:\\ from\\ pathophysiology\\ to\\ therapy\\.\\ nat\\ rev\\ rheumatol\\.\\ 2011\\;7\\(9\\)\\:518\\.\ \(0\)\
\-\ unenhanced\\ multiplanar\\ 3\\-t\\ mri\\ imaging\\ of\\ the\\ lumbar\\ spine\\ from\\ t11\\-12\\ to\\ l5\\-s1\\:\ \(0\)\
\-\ \\â\\€\\¢\\ the\\ conus\\ terminates\\ at\\ the\\ level\\ of\\ the\\ t12\\-l1\\ disc\\ space\\,\\ and\\ within\\ limits\\ of\\ the\\ study\\.\\ no\\ distal\\ cord\\ abnormality\\ is\\ seen\\.\ \(0\)\
\-\ \\â\\€\\¢\\ at\\ t11\\-12\\,\\ t12\\-l1\\,\\ l1\\-l2\\,\\ l2\\-l3\\,\\ and\\ l3\\-l4\\,\\ the\\ canal\\ and\\ the\\ neural\\ foramina\\ are\\ patent\\.\\ there\\ is\\ no\\ annular\\ bulge\\.\\ the\\ discs\\ are\\ well\\ hydrated\\.\ \(0\)\
\-\ \\â\\€\\¢\\ at\\ l4\\-5\\,\\ there\\ is\\ a\\ shallow\\ annular\\ bulge\\ and\\ mild\\ facet\\ arthropathy\\.\\ overall\\,\\ the\\ canal\\ and\\ the\\ neural\\ foramina\\ still\\ maintain\\ their\\ caliber\\.\ \(0\)\
\-\ \\â\\€\\¢\\ at\\ l5\\-s1\\,\\ the\\ canal\\ tapers\\ in\\ diameter\\ due\\ to\\ increased\\ deposition\\ of\\ epidural\\ fat\\.\\ the\\ disc\\ remains\\ well\\ hydrated\\ and\\ the\\ neural\\ foramina\\ are\\ patent\\.\ \(0\)\
\-\ patient\\ photos\\:\ \(0\)\
\-\ \\â\\€\\¢\\ diffuse\\ macules\\ and\\ patches\\ chest\\,\\ abdomen\\,\\ and\\ thighs\\ with\\ sloughing\\ and\\ epidermal\\ loss\\ \\â\\€\\“\\ characteristic\\ of\\ stevens\\-johnson\\ syndrome\\.\ \(0\)\
\-\ post\\ stevens\\-johnson\\ syndrome\\,\\ resembling\\ fibromyalgia\ \(0\)\
\-\ \\â\\€\\¢\\ fibromyalgia\ \(0\)\
\-\ \\â\\€\\¢\\ recurrent\\ arthralgia\\ secondary\\ to\\ stevens\\-johnson\\ syndrome\ \(0\)\
\-\ \\â\\€\\¢\\ myofascial\\ pain\\ syndrome\\ \\(mps\\)\ \(0\)\
\-\ \\â\\€\\¢\\ chronic\\ fatigue\\ syndrome\\ \\(cfs\\)\ \(0\)\
\-\ \\â\\€\\¢\\ cervical\\ and\\ lumbar\\ disc\\ herniations\ \(0\)\
\-\ this\\ is\\ a\\ 22\\ woman\\ who\\ was\\ referred\\ for\\ further\\ diagnosis\\ of\\ her\\ worsening\\ pain\\ in\\ her\\ neck\\ and\\ low\\ back\\.\\ she\\ first\\ noticed\\ the\\ pain\\ after\\ recovering\\ from\\ stevens\\-johnson\\ syndrome\\ in\\ about\\ 14\\ months\\ ago\\,\\ following\\ the\\ use\\ of\\ bactrim\\ for\\ mastitis\\.\\ she\\ states\\ that\\ her\\ neck\\ and\\ low\\ back\\ pain\\ is\\ constant\\,\\ and\\ is\\ described\\ it\\ as\\ a\\ nagging\\ ache\\ with\\ a\\ deep\\ stabbing\\ sensation\\ when\\ aggravated\\.\\ \\ her\\ neck\\ pain\\ is\\ aggravated\\ by\\ movement\\ and\\ physical\\ activity\\ \\(e\\.g\\.\\ cradling\\ her\\ baby\\)\\,\\ and\\ radiates\\ to\\ her\\ shoulders\\.\\ her\\ low\\ back\\ pain\\ is\\ also\\ aggravated\\ by\\ movement\\ and\\ physical\\ activity\\,\\ and\\ radiates\\ to\\ her\\ buttocks\\ and\\ thighs\\ bilaterally\\.\\ she\\ also\\ states\\ that\\ her\\ arms\\ and\\ legs\\ feel\\ weaker\\,\\ especially\\ on\\ the\\ left\\ side\\.\\ she\\ denies\\ any\\ associated\\ fevers\\,\\ headaches\\,\\ or\\ loss\\ of\\ function\\ of\\ any\\ muscles\\/extremities\\.\\ she\\ has\\ tried\\ using\\ nsaids\\,\\ specifically\\ aspirin\\ and\\ ibuprofen\\,\\ but\\ they\\ have\\ provided\\ little\\ relief\\.\\ patient\\ rates\\ her\\ current\\ discomfort\\ at\\ a\\ 5\\/10\\,\\ but\\ rates\\ her\\ maximum\\ pain\\ when\\ aggravated\\ at\\ an\\ 8\\/10\\.\\ she\\ does\\ not\\ recall\\ ever\\ having\\ a\\ similar\\ episode\\ of\\ neck\\ and\\ low\\ back\\ pain\\ in\\ the\\ past\\.\ \(0\)\
\-\ her\\ past\\ medical\\ history\\ is\\ significant\\ for\\ stevens\\-johnson\\ syndrome\\ with\\ dermatological\\ and\\ ophthalmic\\ sequelae\\.\\ \\ patient\\ is\\ not\\ on\\ any\\ medications\\,\\ is\\ allergic\\ to\\ bactrim\\,\\ and\\ denies\\ alcohol\\,\\ tobacco\\,\\ or\\ illicit\\/iv\\ drug\\ use\\.\ \(0\)\
\-\ case\\ contributors\\:michael\\ r\\ carag\\,\\ msiii\\,\\ joanna\\ garvey\\,\\ dc\\;\\ geoffrey\\ gerow\\,\\ dc\\;\\ randall\\ loftus\\,\\ md\\;\\ krishnan\\ kartha\\,\\ md\\;\\ joseph\\ serghany\\,\\ md\\;\\ charles\\ tirone\\ md\\,\\ vaseem\\ iqbqal\\ md\\.\\ \ \(0\)\
\-\ fibromyalgia\\ is\\ a\\ chronic\\ condition\\ characterized\\ by\\ widespread\\ pain\\ and\\ increased\\ sensitivity\\ to\\ pressure\\ \\[1\\]\\.\\ prominent\\ concomitant\\ symptoms\\ include\\ chronic\\ fatigue\\,\\ cold\\ extremities\\,\\ cognitive\\ dysfunction\\,\\ sleep\\ disturbances\\,\\ anxiety\\ and\\/or\\ depression\\,\\ gait\\ instability\\,\\ and\\ muscle\\ twitching\\ \\[2\\]\\.\\ diagnosis\\ is\\ made\\ according\\ to\\ the\\ american\\ college\\ of\\ rheumatology\\ guidelines\\,\\ which\\ requires\\ that\\ three\\ conditions\\ are\\ met\\ \\[3\\]\\:\\ \ \(0\)\
\-\ 1\\.\\ a\\ widespread\\ pain\\ index\\ \\(wpi\\)\\ \\>\\ 7\\ and\\ symptom\\ severity\\ \\(ss\\)\\ scale\\ score\\ \\>\\ 5\\ or\\ wpi\\ 3\\-6\\ and\\ ss\\ \\>\\ 9\\.\ \(0\)\
\-\ 2\\.\\ persistent\\ symptoms\\ for\\ at\\ least\\ 3\\ months\\.\\ \ \(0\)\
\-\ 3\\.\\ no\\ other\\ disorder\\ that\\ would\\ otherwise\\ explain\\ the\\ pain\\.\ \(0\)\
\-\ wpi\\ is\\ scored\\ on\\ a\\ 0\\-19\\ scale\\,\\ with\\ one\\ point\\ assigned\\ if\\ the\\ patient\\ has\\ experienced\\ pain\\ over\\ the\\ last\\ week\\ in\\ various\\ locations\\:\\ r\\/l\\ shoulder\\ girdle\\;\\ r\\/l\\ upper\\ arm\\;\\ r\\/l\\ lower\\ arm\\;\\ r\\/l\\ hip\\;\\ r\\/l\\ upper\\ leg\\;\\ r\\/l\\ lower\\ leg\\;\\ r\\/l\\ jaw\\;\\ chest\\;\\ abdomen\\;\\ upper\\ back\\;\\ lower\\ back\\;\\ and\\ neck\\.\\ symptom\\ severity\\ score\\ asks\\ the\\ patient\\ to\\ rate\\ level\\ of\\ fatigue\\,\\ waking\\ unfreshed\\,\\ and\\ cognitive\\ symptoms\\ each\\ from\\ 0\\ \\(no\\ problem\\)\\ to\\ 3\\ \\(severe\\ problem\\)\\.\\ \\ \ \(0\)\
\-\ the\\ cause\\ of\\ fibromyalgia\\ is\\ unknown\\,\\ however\\ studies\\ postulate\\ that\\ a\\ stressor\\ triggering\\ abnormal\\ central\\ nervous\\ system\\ pain\\ processing\\ \\â\\€\\“\\ central\\ sensitization\\ \\â\\€\\“\\ is\\ to\\ blame\\ \\[4\\]\\.\\ psychological\\ stressors\\ \\â\\€\\“\\ death\\ of\\ a\\ loved\\ one\\,\\ prolonged\\ hospitalization\\,\\ trauma\\ or\\ mva\\[5\\]\\ \\ \\â\\€\\“\\ and\\ biological\\ stressors\\ \\â\\€\\“\\ infections\\ \\(lyme\\ disease\\,\\ ebv\\,\\ parvovirus\\,\\ q\\ fever\\)\\,\\ acute\\ gi\\ \\ infections\\ \\(campylobacter\\,\\ salmonella\\,\\ shigella\\)\\,\\ status\\-post\\ surgery\\ or\\ prolonged\\ illness\\ \\â\\€\\“\\ are\\ all\\ associated\\ with\\ an\\ increased\\ risk\\ of\\ developing\\ fibromyalgia\\ \\[1\\]\\.\\ further\\ studies\\ have\\ also\\ noted\\ an\\ aggregation\\ of\\ fibromyalgia\\ in\\ patient\\ families\\ and\\ specific\\ polymorphisms\\ in\\ serotoninergic\\,\\ dopaminergic\\,\\ and\\ catecholaminergic\\ systems\\,\\ suggesting\\ a\\ polygenic\\ mode\\ of\\ inheritance\\ \\[6\\]\\.\ \(0\)\
\-\ with\\ regards\\ to\\ our\\ lg\\,\\ wpi\\ was\\ scored\\ at\\ 18\\ out\\ of\\ 19\\,\\ with\\ pain\\ experienced\\ everywhere\\ but\\ the\\ jaw\\.\\ ss\\ scale\\ score\\ was\\ also\\ greater\\ than\\ 5\\,\\ with\\ lg\\ complaining\\ of\\ all\\ three\\ symptoms\\.\\ furthermore\\,\\ in\\ relation\\ to\\ the\\ 1990\\ american\\ college\\ of\\ rheumatology\\ guidelines\\ for\\ fibromyalgia\\ diagnosis\\,\\ pain\\ upon\\ palpation\\ was\\ elicited\\ at\\ 17\\ out\\ of\\ the\\ 18\\ tenderness\\ points\\,\\ excluding\\ the\\ anterior\\ aspects\\ of\\ inter\\-transverse\\ spaces\\ between\\ c5\\ and\\ c7\\ \\[2\\]\\.\\ given\\ these\\ findings\\ through\\ the\\ history\\ of\\ present\\ illness\\,\\ review\\ of\\ symptoms\\,\\ and\\ physical\\ exam\\,\\ paired\\ with\\ a\\ negative\\ mri\\ of\\ the\\ lumbar\\ spine\\,\\ we\\ concluded\\ that\\ the\\ condition\\ affecting\\ lg\\ most\\ closely\\ correlated\\ with\\ fibromyalgia\\,\\ likely\\ secondary\\ to\\ her\\ recent\\ episode\\ of\\ stevens\\-johnson\\ syndrome\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ schmidt\\-wilcke\\ t\\,\\ clauw\\ dj\\.\\ fibromyalgia\\:\\ from\\ pathophysiology\\ to\\ therapy\\.\\ nat\\ rev\\ rheumatol\\.\\ 2011\\;7\\(9\\)\\:518\\.\ \(0\)\
\-\ 2\\.\\ chaitow\\ l\\,\\ et\\ al\\.\\ fibromyalgia\\ syndrome\\:\\ a\\ practitioner\\â\\€\\™s\\ guide\\ to\\ treatment\\.\\ new\\ york\\:\\ churchill\\ livingston\\;\\ 2000\\.\ \(0\)\
\-\ 3\\.\\ wolfe\\ f\\,\\ et\\ al\\.\\ the\\ american\\ college\\ of\\ rheumatology\\ preliminary\\ diagnostic\\ criteria\\ for\\ fibromyalgia\\ and\\ measurement\\ of\\ symptom\\ severity\\.\\ arthritis\\ care\\ res\\ \\(hoboken\\)\\.\\ 2010\\ may\\;62\\(5\\)\\:600\\-10\\.\ \(0\)\
\-\ 4\\.\\ bernstein\\ cd\\,\\ weiner\\ dk\\.\\ chapter\\ 123\\.\\ fibromyalgia\\ and\\ myofascial\\ pain\\ syndromes\\.\\ in\\:\\ halter\\ jb\\,\\ ouslander\\ jg\\,\\ tinetti\\ me\\,\\ studenski\\ s\\,\\ high\\ kp\\,\\ asthana\\ s\\,\\ eds\\.\\ hazzard\\'s\\ geriatric\\ medicine\\ and\\ gerontology\\.\\ 6th\\ ed\\.\\ new\\ york\\:\\ mcgraw\\-hill\\;\\ 2009\\.\\ http\\:\\/\\/www\\.accessmedicine\\.com\\/content\\.aspx\\?aid\\=5136432\\.\\ accessed\\ march\\ 7\\,\\ 2013\\.\ \(0\)\
\-\ 5\\.\\ papageorgiou\\,\\ a\\.\\ c\\.\\,\\ silman\\,\\ a\\.\\ j\\.\\ \\&\\ macfarlane\\,\\ g\\.\\ j\\.\\ chronic\\ widespread\\ pain\\ in\\ the\\ population\\:\\ a\\ seven\\ year\\ follow\\ up\\ study\\.\\ ann\\.\\ rheum\\.\\ dis\\.\\ 61\\,\\ 1071\\-1074\\ \\(2002\\)\\.\ \(0\)\
\-\ 6\\.\\ buskila\\ d\\,\\ sarzi\\-puttini\\ p\\.\\ biology\\ and\\ therapy\\ of\\ fibromyalgia\\.\\ genetic\\ aspects\\ of\\ fibromyalgia\\ syndrome\\.\\ arthritis\\ res\\ ther\\.\\ 2006\\;8\\(5\\)\\:218\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ fibromyalgia\\:\\ 0\\.0609106467619594\ \(0\)\
\-\ \\;\\:\\ 0\\.04830272752949275\ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.041076568175399085\ \(0\)\
\-\ \\]\\:\\ 0\\.03635539026107979\ \(0\)\
\-\ \\[\\:\\ 0\\.03625048453070656\ \(0\)\
\-\ r\\/l\\:\\ 0\\.03344641136464254\ \(0\)\
\-\ l\\:\\ 0\\.0295596341322153\ \(0\)\
\-\ stevens\\-johnson\\:\\ 0\\.028668352598265036\ \(0\)\
\-\ 5\\/5\\:\\ 0\\.028350043115241665\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.02709710927754822\ \(0\)\
\-\ elicits\\:\\ 0\\.02201184618809364\ \(0\)\
\-\ wpi\\:\\ 0\\.019112235065510023\ \(0\)\
\-\ r\\:\\ 0\\.01893192434554052\ \(0\)\
\-\ back\\:\\ 0\\.01833539079900798\ \(0\)\
\-\ her\\:\\ 0\\.018104255588240737\ \(0\)\
\-\ \\:\\:\\ 0\\.01715322213969573\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.016986605437353797\ \(0\)\
\-\ \\,\\:\\ 0\\.016286621827869323\ \(0\)\
\-\ lumbar\\:\\ 0\\.01575603197257198\ \(0\)\
\-\ pain\\:\\ 0\\.01414103208036226\ \(0\)\
\-\ aggravated\\:\\ 0\\.013390701559569083\ \(0\)\
\-\ syndrome\\:\\ 0\\.013246106106962826\ \(0\)\
\-\ flexion\\:\\ 0\\.012789321955707731\ \(0\)\
\-\ lg\\:\\ 0\\.01254781485414372\ \(0\)\
\-\ extension\\:\\ 0\\.011573057587139064\ \(0\)\
\-\ md\\:\\ 0\\.011437394509029562\ \(0\)\
\-\ leg\\:\\ 0\\.010927470922305029\ \(0\)\
\-\ \\%\\:\\ 0\\.01080390803981576\ \(0\)\
\-\ ss\\:\\ 0\\.01043515959539533\ \(0\)\
\-\ low\\:\\ 0\\.010303167708905797\ \(0\)\
\-\ thighs\\:\\ 0\\.010163526937406442\ \(0\)\
\-\ rheumatology\\:\\ 0\\.010163526937406442\ \(0\)\
\-\ college\\:\\ 0\\.010043026169676813\ \(0\)\
\-\ 1\\:\\ 0\\.009918665209559545\ \(0\)\
\-\ guidelines\\:\\ 0\\.00972732533318745\ \(0\)\
\-\ inter\\-transverse\\:\\ 0\\.009556117532755011\ \(0\)\
\-\ schmidt\\-wilcke\\:\\ 0\\.009556117532755011\ \(0\)\
\-\ clauw\\:\\ 0\\.009556117532755011\ \(0\)\
\-\ stressors\\:\\ 0\\.009556117532755011\ \(0\)\
\-\ buttocks\\:\\ 0\\.009463066911239848\ \(0\)\
\-\ \\(\\:\\ 0\\.009396575300733146\ \(0\)\
\-\ widespread\\:\\ 0\\.009308091009118995\ \(0\)\
\-\ \\)\\:\\ 0\\.009281791116921042\ \(0\)\
\-\ score\\:\\ 0\\.008975091964166128\ \(0\)\
\-\ upper\\:\\ 0\\.008941270483983603\ \(0\)\
\-\ radiates\\:\\ 0\\.008648798150406532\ \(0\)\
\-\ foramina\\:\\ 0\\.00841940205567498\ \(0\)\
\-\ cervical\\:\\ 0\\.00841488186068192\ \(0\)\
\-\ arthralgia\\:\\ 0\\.008365209902762481\ \(0\)\
\-\ nat\\:\\ 0\\.008365209902762481\ \(0\)\
\-\ myofascial\\:\\ 0\\.008365209902762481\ \(0\)\
\-\ on\\:\\ 0\\.008239409896842272\ \(0\)\
\-\ neck\\:\\ 0\\.008160140282986934\ \(0\)\
\-\ rheumatol\\:\\ 0\\.0080533594177199\ \(0\)\
\-\ bactrim\\:\\ 0\\.0080533594177199\ \(0\)\
\-\ 4\\/5\\:\\ 0\\.008039540509038386\ \(0\)\
\-\ aspects\\:\\ 0\\.008006013212773775\ \(0\)\
\-\ scale\\:\\ 0\\.007940963888198654\ \(0\)\
\-\ raise\\:\\ 0\\.007909389764853773\ \(0\)\
\-\ symptom\\:\\ 0\\.007878417090104678\ \(0\)\
\-\ sensitivity\\:\\ 0\\.007848023377889795\ \(0\)\
\-\ dj\\:\\ 0\\.007811469389195011\ \(0\)\
\-\ t11\\-12\\:\\ 0\\.007811469389195011\ \(0\)\
\-\ she\\:\\ 0\\.0078009305413143815\ \(0\)\
\-\ hydrated\\:\\ 0\\.007613830845244925\ \(0\)\
\-\ scored\\:\\ 0\\.007613830845244925\ \(0\)\
\-\ severity\\:\\ 0\\.00754655472206644\ \(0\)\
\-\ at\\:\\ 0\\.007530166847685418\ \(0\)\
\-\ fatigue\\:\\ 0\\.007426053954336811\ \(0\)\
\-\ rev\\:\\ 0\\.007301980360202344\ \(0\)\
\-\ t12\\-l1\\:\\ 0\\.0071743022727699494\ \(0\)\
\-\ res\\:\\ 0\\.0071743022727699494\ \(0\)\
\-\ deficit\\:\\ 0\\.007168779149109341\ \(0\)\
\-\ 7\\:\\ 0\\.007098655563811538\ \(0\)\
\-\ hallux\\:\\ 0\\.007060090331677455\ \(0\)\
\-\ neural\\:\\ 0\\.007035580575990827\ \(0\)\
\-\ 5\\:\\ 0\\.006775502499848682\ \(0\)\
\-\ muscle\\:\\ 0\\.006654341969488011\ \(0\)\
\-\ american\\:\\ 0\\.006618839505045932\ \(0\)\
\-\ disc\\:\\ 0\\.00647030327969922\ \(0\)\
\-\ buttock\\:\\ 0\\.00620539400607933\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.00620539400607933\ \(0\)\
\-\ cognitive\\:\\ 0\\.006157207813590622\ \(0\)\
\-\ surface\\:\\ 0\\.006133485052109352\ \(0\)\
\-\ spine\\:\\ 0\\.006101037498114575\ \(0\)\
\-\ york\\:\\ 0\\.006066821245635011\ \(0\)\
\-\ c5\\:\\ 0\\.006024305567420072\ \(0\)\
\-\ to\\:\\ 0\\.006018303967218234\ \(0\)\
\-\ jaw\\:\\ 0\\.005905932351197857\ \(0\)\
\-\ elicited\\:\\ 0\\.005869182701684924\ \(0\)\
\-\ c7\\:\\ 0\\.005869182701684924\ \(0\)\
\-\ 2011\\:\\ 0\\.005869182701684924\ \(0\)\
\-\ limited\\:\\ 0\\.005863467107520451\ \(0\)\
\-\ denies\\:\\ 0\\.005863467107520451\ \(0\)\
\-\ normal\\:\\ 0\\.0058086176893185956\ \(0\)\
\-\ 1\\.\\:\\ 0\\.00578685998113301\ \(0\)\
\-\ references\\:\\ 0\\.00577695647977498\ \(0\)\
\-\ symptoms\\:\\ 0\\.005771429476688724\ \(0\)\
\-\ 9\\:\\ 0\\.005743601130452861\ \(0\)\
\-\ annular\\:\\ 0\\.005733504497940745\ \(0\)\
\-\ increased\\:\\ 0\\.005665270411381181\ \(0\)\
\-\ diffuse\\:\\ 0\\.005608688174255425\ \(0\)\
\-\ shoulder\\:\\ 0\\.005601431537949326\ \(0\)\
\-\ that\\:\\ 0\\.00559992688342101\ \(0\)\
\-\ hip\\:\\ 0\\.005534751824571477\ \(0\)\
\-\ canal\\:\\ 0\\.005520298251535305\ \(0\)\
\-\ is\\:\\ 0\\.005485763691558299\ \(0\)\
\-\ extremities\\:\\ 0\\.0054498969413672976\ \(0\)\
\-\ l5\\-s1\\:\\ 0\\.005405828756073066\ \(0\)\
\-\ knees\\:\\ 0\\.005382515796483946\ \(0\)\
\-\ rates\\:\\ 0\\.005382515796483946\ \(0\)\
\-\ plantar\\:\\ 0\\.005293975925465769\ \(0\)\
\-\ and\\:\\ 0\\.005268556265333223\ \(0\)\
\-\ chronic\\:\\ 0\\.005218405708199458\ \(0\)\
\-\ a\\.\\:\\ 0\\.005192592664749429\ \(0\)\
\-\ bending\\:\\ 0\\.005173406131308345\ \(0\)\
\-\ bulge\\:\\ 0\\.005173406131308345\ \(0\)\
\-\ illness\\:\\ 0\\.005154553293680302\ \(0\)\
\-\ thigh\\:\\ 0\\.005064914577317036\ \(0\)\
\-\ diminished\\:\\ 0\\.005064914577317036\ \(0\)\
\-\ problem\\:\\ 0\\.005064914577317036\ \(0\)\
\-\ distal\\:\\ 0\\.005036918350018486\ \(0\)\
\-\ legs\\:\\ 0\\.005014486376086799\ \(0\)\
\-\ touch\\:\\ 0\\.004998185154011418\ \(0\)\
\-\ straight\\:\\ 0\\.0049507026362245405\ \(0\)\
\-\ prolonged\\:\\ 0\\.004920165100217282\ \(0\)\
\-\ dc\\:\\ 0\\.004905212989504724\ \(0\)\
\-\ or\\:\\ 0\\.004885476824213208\ \(0\)\
\-\ experienced\\:\\ 0\\.004805953159124787\ \(0\)\
\-\ elbow\\:\\ 0\\.0047791860994062275\ \(0\)\
\-\ algometer\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ epicondyles\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ abduction\\-\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ 60lbs\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ 55lbs\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ r\\-handed\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ cocchiarella\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ andersson\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ gbj\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ 5e\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ over\\-the\\-counter\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ tri\\-cyclic\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ antidepressants\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ serotonin\\-norepinephrine\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ duloxetine\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ milnacipran\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ gabapentinoids\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ \\:518\\.\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ 3\\-t\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ cradling\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ muscles\\/extremities\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ illicit\\/iv\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ carag\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ 0\\-19\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ unfreshed\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ postulate\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ stressor\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ blame\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ loved\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ serotoninergic\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ catecholaminergic\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ \\:518\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ chaitow\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ wolfe\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ hoboken\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ \\:600\\-10\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ weiner\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ 123\\.\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ ouslander\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ tinetti\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ studenski\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ asthana\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ hazzard\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ gerontology\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ \\/\\/www\\.accessmedicine\\.com\\/content\\.aspx\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ aid\\=5136432\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ papageorgiou\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ silman\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ macfarlane\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ 1071\\-1074\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ sarzi\\-puttini\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ \\:218\\:\\ 0\\.004778058766377506\ \(0\)\
\-\ relief\\:\\ 0\\.004727556778008661\ \(0\)\
\-\ movement\\:\\ 0\\.00463113673896639\ \(0\)\
\-\ \\>\\:\\ 0\\.004616532544176527\ \(0\)\
\-\ episode\\:\\ 0\\.004585963084331627\ \(0\)\
\-\ study\\:\\ 0\\.004571758303837332\ \(0\)\
\-\ spaces\\:\\ 0\\.004564063130599898\ \(0\)\
\-\ patent\\:\\ 0\\.004564063130599898\ \(0\)\
\-\ bilaterally\\:\\ 0\\.00456374835532342\ \(0\)\
\-\ further\\:\\ 0\\.004418608360650826\ \(0\)\
\-\ infections\\:\\ 0\\.004403174236162747\ \(0\)\
\-\ piriformis\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ 26\\.1\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ 19\\.7\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ 26\\.7\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ eruptions\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ reuptake\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ pregabalin\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ mps\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ dermatological\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ asks\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ sensitization\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ parvovirus\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ dopaminergic\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ polygenic\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ practitioner\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ livingston\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ dk\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ halter\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ kp\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ buskila\\:\\ 0\\.004402369237618728\ \(0\)\
\-\ any\\:\\ 0\\.004375341517190721\ \(0\)\
\-\ states\\:\\ 0\\.004357428594438761\ \(0\)\
\-\ light\\:\\ 0\\.00432217310207501\ \(0\)\
\-\ gait\\:\\ 0\\.00431353551979948\ \(0\)\
\-\ t\\:\\ 0\\.004288028205533687\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004254134050472455\ \(0\)\
\-\ chicago\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ cfs\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ nagging\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ triggering\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ processing\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ psychological\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ aggregation\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ everywhere\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ geriatric\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ biology\\:\\ 0\\.004182604951381241\ \(0\)\
\-\ lower\\:\\ 0\\.004166638632767182\ \(0\)\
\-\ left\\:\\ 0\\.004145713904706405\ \(0\)\
\-\ abdomen\\:\\ 0\\.004116071972188124\ \(0\)\
\-\ in\\:\\ 0\\.004111192489173219\ \(0\)\
\-\ needed\\:\\ 0\\.0040344370982761365\ \(0\)\
\-\ gabapentin\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ tapers\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ photos\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ sloughing\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ 5\\/10\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ iqbqal\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ assigned\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ girdle\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ waking\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ campylobacter\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ families\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ polymorphisms\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ mode\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ paired\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ bernstein\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ jg\\:\\ 0\\.00402667970885995\ \(0\)\
\-\ 18\\:\\ 0\\.004021217290044355\ \(0\)\
\-\ lateral\\:\\ 0\\.0040036163590776155\ \(0\)\
\-\ s\\:\\ 0\\.003984988076609085\ \(0\)\
\-\ arthritis\\:\\ 0\\.003957433550182097\ \(0\)\
\-\ al\\:\\ 0\\.0039268960141748376\ \(0\)\
\-\ midpoint\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ spines\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ centimeters\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ press\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ weaker\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ michael\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ biological\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ q\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ inheritance\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ rheum\\:\\ 0\\.0039057346945975055\ \(0\)\
\-\ arm\\:\\ 0\\.0038797576814488337\ \(0\)\
\-\ condition\\:\\ 0\\.003874006947324505\ \(0\)\
\-\ especially\\:\\ 0\\.0038126840730823433\ \(0\)\
\-\ \\+2\\:\\ 0\\.0038069154226224623\ \(0\)\
\-\ modifications\\:\\ 0\\.0038069154226224623\ \(0\)\
\-\ shigella\\:\\ 0\\.0038069154226224623\ \(0\)\
\-\ 2009\\.\\:\\ 0\\.0038069154226224623\ \(0\)\
\-\ et\\:\\ 0\\.003791217810430658\ \(0\)\
\-\ deep\\:\\ 0\\.0037495199450346727\ \(0\)\
\-\ aligned\\:\\ 0\\.0037233649186510487\ \(0\)\
\-\ pigmentation\\:\\ 0\\.0037233649186510487\ \(0\)\
\-\ acetaminophen\\:\\ 0\\.0037233649186510487\ \(0\)\
\-\ alleviate\\:\\ 0\\.0037233649186510487\ \(0\)\
\-\ amitriptyline\\:\\ 0\\.0037233649186510487\ \(0\)\
\-\ resembling\\:\\ 0\\.0037233649186510487\ \(0\)\
\-\ twitching\\:\\ 0\\.0037233649186510487\ \(0\)\
\-\ excluding\\:\\ 0\\.0037233649186510487\ \(0\)\
\-\ therapy\\:\\ 0\\.00371486308331807\ \(0\)\
\-\ patient\\:\\ 0\\.003714219754651005\ \(0\)\
\-\ use\\:\\ 0\\.0036611806125130654\ \(0\)\
\-\ also\\:\\ 0\\.003652291801994908\ \(0\)\
\-\ insertions\\:\\ 0\\.003650990180101172\ \(0\)\
\-\ costochondral\\:\\ 0\\.003650990180101172\ \(0\)\
\-\ junctions\\:\\ 0\\.003650990180101172\ \(0\)\
\-\ lifestyle\\:\\ 0\\.003650990180101172\ \(0\)\
\-\ jb\\:\\ 0\\.003650990180101172\ \(0\)\
\-\ me\\:\\ 0\\.003650990180101172\ \(0\)\
\-\ mcgraw\\-hill\\:\\ 0\\.003650990180101172\ \(0\)\
\-\ ther\\:\\ 0\\.003650990180101172\ \(0\)\
\-\ elbows\\:\\ 0\\.0035871511363849747\ \(0\)\
\-\ monofilament\\:\\ 0\\.0035871511363849747\ \(0\)\
\-\ ama\\:\\ 0\\.0035871511363849747\ \(0\)\
\-\ terminates\\:\\ 0\\.0035871511363849747\ \(0\)\
\-\ l1\\-l2\\:\\ 0\\.0035871511363849747\ \(0\)\
\-\ macules\\:\\ 0\\.0035871511363849747\ \(0\)\
\-\ mastitis\\:\\ 0\\.0035871511363849747\ \(0\)\
\-\ preliminary\\:\\ 0\\.0035871511363849747\ \(0\)\
\-\ cd\\:\\ 0\\.0035871511363849747\ \(0\)\
\-\ brachioradialis\\:\\ 0\\.0035300451658387276\ \(0\)\
\-\ cyclobenzaprine\\:\\ 0\\.0035300451658387276\ \(0\)\
\-\ stabbing\\:\\ 0\\.0035300451658387276\ \(0\)\
\-\ ever\\:\\ 0\\.0035300451658387276\ \(0\)\
\-\ salmonella\\:\\ 0\\.0035300451658387276\ \(0\)\
\-\ churchill\\:\\ 0\\.0035300451658387276\ \(0\)\
\-\ as\\:\\ 0\\.003502920070173788\ \(0\)\
\-\ trapezius\\:\\ 0\\.0034783865317984434\ \(0\)\
\-\ ache\\:\\ 0\\.0034783865317984434\ \(0\)\
\-\ 8\\/10\\:\\ 0\\.0034783865317984434\ \(0\)\
\-\ regards\\:\\ 0\\.0034783865317984434\ \(0\)\
\-\ ann\\:\\ 0\\.0034783865317984434\ \(0\)\
\-\ dis\\:\\ 0\\.0034783865317984434\ \(0\)\
\-\ activity\\:\\ 0\\.0034753892994921825\ \(0\)\
\-\ studies\\:\\ 0\\.00345962159108852\ \(0\)\
\-\ a\\:\\ 0\\.0034393478748496586\ \(0\)\
\-\ from\\:\\ 0\\.0034320751033989493\ \(0\)\
\-\ 2001\\.\\:\\ 0\\.0034312258938636844\ \(0\)\
\-\ inhibitors\\:\\ 0\\.0034312258938636844\ \(0\)\
\-\ patches\\:\\ 0\\.0034312258938636844\ \(0\)\
\-\ feel\\:\\ 0\\.0034312258938636844\ \(0\)\
\-\ recall\\:\\ 0\\.0034312258938636844\ \(0\)\
\-\ chapter\\:\\ 0\\.0034312258938636844\ \(0\)\
\-\ right\\:\\ 0\\.003420824912614047\ \(0\)\
\-\ physical\\:\\ 0\\.003408951657855672\ \(0\)\
\-\ suboccipital\\:\\ 0\\.0033878423124688137\ \(0\)\
\-\ instructed\\:\\ 0\\.0033878423124688137\ \(0\)\
\-\ l2\\-l3\\:\\ 0\\.0033878423124688137\ \(0\)\
\-\ the\\:\\ 0\\.003371933773259166\ \(0\)\
\-\ thorough\\:\\ 0\\.003347675389892271\ \(0\)\
\-\ ebv\\:\\ 0\\.003347675389892271\ \(0\)\
\-\ guide\\:\\ 0\\.003347675389892271\ \(0\)\
\-\ eds\\:\\ 0\\.003347675389892271\ \(0\)\
\-\ care\\:\\ 0\\.003341113438556913\ \(0\)\
\-\ chest\\:\\ 0\\.0033247626017195425\ \(0\)\
\-\ doses\\:\\ 0\\.00331028087960124\ \(0\)\
\-\ recovering\\:\\ 0\\.00331028087960124\ \(0\)\
\-\ concluded\\:\\ 0\\.00331028087960124\ \(0\)\
\-\ explain\\:\\ 0\\.0032753006513423937\ \(0\)\
\-\ no\\:\\ 0\\.0032645577533477583\ \(0\)\
\-\ 3\\:\\ 0\\.0032536187426122597\ \(0\)\
\-\ dynamometer\\:\\ 0\\.00324244177772915\ \(0\)\
\-\ tried\\:\\ 0\\.00324244177772915\ \(0\)\
\-\ met\\:\\ 0\\.00324244177772915\ \(0\)\
\-\ new\\:\\ 0\\.0032279544463962692\ \(0\)\
\-\ of\\:\\ 0\\.0032204302659606557\ \(0\)\
\-\ adequately\\:\\ 0\\.0032114616076261973\ \(0\)\
\-\ jamar\\:\\ 0\\.0032114616076261973\ \(0\)\
\-\ herniations\\:\\ 0\\.0032114616076261973\ \(0\)\
\-\ 3\\-6\\:\\ 0\\.0032114616076261973\ \(0\)\
\-\ correlated\\:\\ 0\\.0032114616076261973\ \(0\)\
\-\ l3\\-l4\\:\\ 0\\.0031821568806504378\ \(0\)\
\-\ epidermal\\:\\ 0\\.0031821568806504378\ \(0\)\
\-\ msiii\\:\\ 0\\.0031821568806504378\ \(0\)\
\-\ 3\\.\\:\\ 0\\.0031695113410739593\ \(0\)\
\-\ for\\:\\ 0\\.0031614445469602824\ \(0\)\
\-\ are\\:\\ 0\\.00315683976295285\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.0031543556370799497\ \(0\)\
\-\ well\\:\\ 0\\.003143221061737644\ \(0\)\
\-\ quadrants\\:\\ 0\\.0031279111036547833\ \(0\)\
\-\ discs\\:\\ 0\\.0031279111036547833\ \(0\)\
\-\ status\\-post\\:\\ 0\\.0031279111036547833\ \(0\)\
\-\ three\\:\\ 0\\.003122627889806949\ \(0\)\
\-\ 1990\\:\\ 0\\.003102697003039665\ \(0\)\
\-\ l4\\-5\\:\\ 0\\.003078603906795311\ \(0\)\
\-\ shallow\\:\\ 0\\.003078603906795311\ \(0\)\
\-\ nervous\\:\\ 0\\.003078603906795311\ \(0\)\
\-\ points\\:\\ 0\\.003078603906795311\ \(0\)\
\-\ out\\:\\ 0\\.003061305015564787\ \(0\)\
\-\ scapula\\:\\ 0\\.003055536365104906\ \(0\)\
\-\ p\\.\\:\\ 0\\.003055536365104906\ \(0\)\
\-\ central\\:\\ 0\\.003047838869224888\ \(0\)\
\-\ aspirin\\:\\ 0\\.0030334106228175053\ \(0\)\
\-\ allergic\\:\\ 0\\.0030334106228175053\ \(0\)\
\-\ disturbances\\:\\ 0\\.0030334106228175053\ \(0\)\
\-\ anxiety\\:\\ 0\\.0030334106228175053\ \(0\)\
\-\ measurement\\:\\ 0\\.0030334106228175053\ \(0\)\
\-\ 6th\\:\\ 0\\.0030334106228175053\ \(0\)\
\-\ ii\\-xii\\:\\ 0\\.003012152783710036\ \(0\)\
\-\ concomitant\\:\\ 0\\.003012152783710036\ \(0\)\
\-\ joint\\:\\ 0\\.002995587268338299\ \(0\)\
\-\ 2\\:\\ 0\\.0029920398317244655\ \(0\)\
\-\ multiplanar\\:\\ 0\\.0029916973213887097\ \(0\)\
\-\ ibuprofen\\:\\ 0\\.0029916973213887097\ \(0\)\
\-\ march\\:\\ 0\\.0029916973213887097\ \(0\)\
\-\ permanent\\:\\ 0\\.0029719858611334925\ \(0\)\
\-\ accessed\\:\\ 0\\.0029719858611334925\ \(0\)\
\-\ but\\:\\ 0\\.002963420001680549\ \(0\)\
\-\ 2013\\:\\ 0\\.0029529661755989286\ \(0\)\
\-\ g\\.\\:\\ 0\\.0029529661755989286\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0029457389071005508\ \(0\)\
\-\ past\\:\\ 0\\.002943305660646541\ \(0\)\
\-\ between\\:\\ 0\\.0029360385216522966\ \(0\)\
\-\ 84\\:\\ 0\\.002916819089149784\ \(0\)\
\-\ relation\\:\\ 0\\.002916819089149784\ \(0\)\
\-\ seven\\:\\ 0\\.002899611122583616\ \(0\)\
\-\ hospitalization\\:\\ 0\\.0028829327168021775\ \(0\)\
\-\ lyme\\:\\ 0\\.0028667522489703723\ \(0\)\
\-\ 2010\\:\\ 0\\.0028667522489703723\ \(0\)\
\-\ unenhanced\\:\\ 0\\.0028510408468710485\ \(0\)\
\-\ diet\\:\\ 0\\.0028357720788674194\ \(0\)\
\-\ maintain\\:\\ 0\\.0028357720788674194\ \(0\)\
\-\ furthermore\\:\\ 0\\.0028357720788674194\ \(0\)\
\-\ constant\\:\\ 0\\.0028209216863535357\ \(0\)\
\-\ tenderness\\:\\ 0\\.0028172491304949954\ \(0\)\
\-\ shoulders\\:\\ 0\\.00280646735189166\ \(0\)\
\-\ conus\\:\\ 0\\.0027923884974725486\ \(0\)\
\-\ tobacco\\:\\ 0\\.0027923884974725486\ \(0\)\
\-\ cold\\:\\ 0\\.0027923884974725486\ \(0\)\
\-\ closely\\:\\ 0\\.0027923884974725486\ \(0\)\
\-\ 67\\:\\ 0\\.0027786661083211714\ \(0\)\
\-\ supraspinatus\\:\\ 0\\.0027786661083211714\ \(0\)\
\-\ 0\\:\\ 0\\.0027786661083211714\ \(0\)\
\-\ impairment\\:\\ 0\\.0027652825784618917\ \(0\)\
\-\ muscular\\:\\ 0\\.002752221574896005\ \(0\)\
\-\ maximum\\:\\ 0\\.002752221574896005\ \(0\)\
\-\ sequelae\\:\\ 0\\.002752221574896005\ \(0\)\
\-\ receive\\:\\ 0\\.002727007474280887\ \(0\)\
\-\ caliber\\:\\ 0\\.002727007474280887\ \(0\)\
\-\ j\\.\\:\\ 0\\.002727007474280887\ \(0\)\
\-\ 61\\:\\ 0\\.002727007474280887\ \(0\)\
\-\ toe\\:\\ 0\\.002702914378036533\ \(0\)\
\-\ triceps\\:\\ 0\\.002702914378036533\ \(0\)\
\-\ depression\\:\\ 0\\.002702914378036533\ \(0\)\
\-\ locations\\:\\ 0\\.002702914378036533\ \(0\)\
\-\ forearm\\:\\ 0\\.002691257898241973\ \(0\)\
\-\ index\\:\\ 0\\.002691257898241973\ \(0\)\
\-\ evaluation\\:\\ 0\\.002690773762413884\ \(0\)\
\-\ loss\\:\\ 0\\.002688850051456303\ \(0\)\
\-\ 2000\\:\\ 0\\.0026798468363461287\ \(0\)\
\-\ c\\.\\:\\ 0\\.0026798468363461287\ \(0\)\
\-\ was\\:\\ 0\\.002678258867787769\ \(0\)\
\-\ level\\:\\ 0\\.0026697984039533136\ \(0\)\
\-\ grip\\:\\ 0\\.0026686710709245914\ \(0\)\
\-\ 2006\\:\\ 0\\.0026686710709245914\ \(0\)\
\-\ take\\:\\ 0\\.0026577210940587274\ \(0\)\
\-\ when\\:\\ 0\\.002652933590911659\ \(0\)\
\-\ tirone\\:\\ 0\\.0026469879627328847\ \(0\)\
\-\ syndromes\\:\\ 0\\.0026469879627328847\ \(0\)\
\-\ abnormal\\:\\ 0\\.0026418344068454324\ \(0\)\
\-\ 68\\:\\ 0\\.0026261390300348925\ \(0\)\
\-\ sleep\\:\\ 0\\.0026261390300348925\ \(0\)\
\-\ all\\:\\ 0\\.0026199712622561417\ \(0\)\
\-\ biceps\\:\\ 0\\.002616007792629932\ \(0\)\
\-\ charles\\:\\ 0\\.002616007792629932\ \(0\)\
\-\ vaseem\\:\\ 0\\.002616007792629932\ \(0\)\
\-\ arthropathy\\:\\ 0\\.0026060624600184427\ \(0\)\
\-\ specifically\\:\\ 0\\.0025962963323747147\ \(0\)\
\-\ secondary\\:\\ 0\\.002589734381039358\ \(0\)\
\-\ 85\\:\\ 0\\.0025867030656541723\ \(0\)\
\-\ deposition\\:\\ 0\\.0025867030656541723\ \(0\)\
\-\ arms\\:\\ 0\\.0025867030656541723\ \(0\)\
\-\ according\\:\\ 0\\.002577276646840151\ \(0\)\
\-\ affecting\\:\\ 0\\.002577276646840151\ \(0\)\
\-\ various\\:\\ 0\\.0025589018220836847\ \(0\)\
\-\ chiropractic\\:\\ 0\\.002541129560391006\ \(0\)\
\-\ noticed\\:\\ 0\\.002532457288658518\ \(0\)\
\-\ criteria\\:\\ 0\\.002532457288658518\ \(0\)\
\-\ 62\\:\\ 0\\.002532457288658518\ \(0\)\
\-\ 2002\\:\\ 0\\.002532457288658518\ \(0\)\
\-\ genetic\\:\\ 0\\.002532457288658518\ \(0\)\
\-\ months\\:\\ 0\\.002530017663620669\ \(0\)\
\-\ 64\\:\\ 0\\.002523921593824838\ \(0\)\
\-\ little\\:\\ 0\\.0025155182406888135\ \(0\)\
\-\ randall\\:\\ 0\\.0025155182406888135\ \(0\)\
\-\ loftus\\:\\ 0\\.0025155182406888135\ \(0\)\
\-\ if\\:\\ 0\\.0025135430176483854\ \(0\)\
\-\ one\\:\\ 0\\.0025102779222879613\ \(0\)\
\-\ insertion\\:\\ 0\\.0025072431880433996\ \(0\)\
\-\ nsaids\\:\\ 0\\.002499092577005709\ \(0\)\
\-\ death\\:\\ 0\\.002499092577005709\ \(0\)\
\-\ protocol\\:\\ 0\\.0024910627202115944\ \(0\)\
\-\ achilles\\:\\ 0\\.0024910627202115944\ \(0\)\
\-\ contributors\\:\\ 0\\.0024753513181122702\ \(0\)\
\-\ dysfunction\\:\\ 0\\.0024676631690651396\ \(0\)\
\-\ outer\\:\\ 0\\.002460082550108641\ \(0\)\
\-\ patellar\\:\\ 0\\.002460082550108641\ \(0\)\
\-\ facet\\:\\ 0\\.002460082550108641\ \(0\)\
\-\ requires\\:\\ 0\\.002460082550108641\ \(0\)\
\-\ systems\\:\\ 0\\.002460082550108641\ \(0\)\
\-\ e\\.g\\:\\ 0\\.002452606494752362\ \(0\)\
\-\ krishnan\\:\\ 0\\.002452606494752362\ \(0\)\
\-\ kartha\\:\\ 0\\.002452606494752362\ \(0\)\
\-\ rom\\:\\ 0\\.002445232157594758\ \(0\)\
\-\ we\\:\\ 0\\.0024379568078212403\ \(0\)\
\-\ joanna\\:\\ 0\\.002430777823132882\ \(0\)\
\-\ garvey\\:\\ 0\\.002430777823132882\ \(0\)\
\-\ serghany\\:\\ 0\\.002430777823132882\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.002423692684071986\ \(0\)\
\-\ geoffrey\\:\\ 0\\.002423692684071986\ \(0\)\
\-\ gerow\\:\\ 0\\.002423692684071986\ \(0\)\
\-\ developing\\:\\ 0\\.002423692684071986\ \(0\)\
\-\ continues\\:\\ 0\\.0024166989687137703\ \(0\)\
\-\ f\\:\\ 0\\.0024166989687137703\ \(0\)\
\-\ population\\:\\ 0\\.0024166989687137703\ \(0\)\
\-\ remains\\:\\ 0\\.0024097943476961933\ \(0\)\
\-\ sensory\\:\\ 0\\.002396243506392444\ \(0\)\
\-\ joseph\\:\\ 0\\.002396243506392444\ \(0\)\
\-\ each\\:\\ 0\\.002396243506392444\ \(0\)\
\-\ anterior\\:\\ 0\\.0023856832777915853\ \(0\)\
\-\ 5th\\:\\ 0\\.002383023206596152\ \(0\)\
\-\ instability\\:\\ 0\\.002383023206596152\ \(0\)\
\-\ exercise\\:\\ 0\\.002376532046137227\ \(0\)\
\-\ drug\\:\\ 0\\.002376532046137227\ \(0\)\
\-\ both\\:\\ 0\\.0023655284451882075\ \(0\)\
\-\ dorsal\\:\\ 0\\.0023575123606026636\ \(0\)\
\-\ nerves\\:\\ 0\\.0023513179455221093\ \(0\)\
\-\ alcohol\\:\\ 0\\.0023331484647423567\ \(0\)\
\-\ discomfort\\:\\ 0\\.0023213652741535186\ \(0\)\
\-\ least\\:\\ 0\\.0023213652741535186\ \(0\)\
\-\ by\\:\\ 0\\.002313611224788414\ \(0\)\
\-\ d\\:\\ 0\\.0023098328088704376\ \(0\)\
\-\ overall\\:\\ 0\\.002304157307587351\ \(0\)\
\-\ characterized\\:\\ 0\\.002304157307587351\ \(0\)\
\-\ conditions\\:\\ 0\\.002304157307587351\ \(0\)\
\-\ mva\\:\\ 0\\.002304157307587351\ \(0\)\
\-\ epidural\\:\\ 0\\.002282031565299949\ \(0\)\
\-\ erythema\\:\\ 0\\.0022766384320461997\ \(0\)\
\-\ complaining\\:\\ 0\\.00226077372619248\ \(0\)\
\-\ baby\\:\\ 0\\.0022555870318747835\ \(0\)\
\-\ 17\\:\\ 0\\.0022555870318747835\ \(0\)\
\-\ suggesting\\:\\ 0\\.0022504495012761147\ \(0\)\
\-\ 6\\.\\:\\ 0\\.0022504495012761147\ \(0\)\
\-\ testing\\:\\ 0\\.0022403182638711535\ \(0\)\
\-\ rotation\\:\\ 0\\.0022254678713572707\ \(0\)\
\-\ border\\:\\ 0\\.0022062798350153106\ \(0\)\
\-\ improved\\:\\ 0\\.0022062798350153106\ \(0\)\
\-\ still\\:\\ 0\\.0022062798350153106\ \(0\)\
\-\ fevers\\:\\ 0\\.0022015871180813733\ \(0\)\
\-\ our\\:\\ 0\\.0022015871180813733\ \(0\)\
\-\ medicine\\:\\ 0\\.0021969346824762827\ \(0\)\
\-\ reflexes\\:\\ 0\\.002192321842547877\ \(0\)\
\-\ associated\\:\\ 0\\.0021858672757807066\ \(0\)\
\-\ current\\:\\ 0\\.002169828763465626\ \(0\)\
\-\ tendon\\:\\ 0\\.002161086551037505\ \(0\)\
\-\ 45\\:\\ 0\\.0021398287119300356\ \(0\)\
\-\ 19\\:\\ 0\\.0021356753933687517\ \(0\)\
\-\ mri\\:\\ 0\\.0021282123088505363\ \(0\)\
\-\ sensation\\:\\ 0\\.002127463032923981\ \(0\)\
\-\ having\\:\\ 0\\.002127463032923981\ \(0\)\
\-\ j\\:\\ 0\\.0020919736403063618\ \(0\)\
\-\ disorder\\:\\ 0\\.002080642103818929\ \(0\)\
\-\ gi\\:\\ 0\\.002080642103818929\ \(0\)\
\-\ 22\\:\\ 0\\.002065892746894872\ \(0\)\
\-\ medications\\:\\ 0\\.002065892746894872\ \(0\)\
\-\ 14\\:\\ 0\\.0020410094399549925\ \(0\)\
\-\ per\\:\\ 0\\.0020272870508036157\ \(0\)\
\-\ their\\:\\ 0\\.0020272870508036157\ \(0\)\
\-\ point\\:\\ 0\\.002023910059068854\ \(0\)\
\-\ 60\\:\\ 0\\.0020205539776336663\ \(0\)\
\-\ development\\:\\ 0\\.0020172185491380682\ \(0\)\
\-\ cranial\\:\\ 0\\.002013903520944336\ \(0\)\
\-\ using\\:\\ 0\\.0020106086450221777\ \(0\)\
\-\ review\\:\\ 0\\.002007333677837374\ \(0\)\
\-\ have\\:\\ 0\\.0020058949358971183\ \(0\)\
\-\ neurological\\:\\ 0\\.0020040783802437634\ \(0\)\
\-\ provided\\:\\ 0\\.0019976258585601217\ \(0\)\
\-\ 5\\.\\:\\ 0\\.0019976258585601217\ \(0\)\
\-\ down\\:\\ 0\\.001988088860245553\ \(0\)\
\-\ test\\:\\ 0\\.0019787167750910484\ \(0\)\
\-\ last\\:\\ 0\\.0019787167750910484\ \(0\)\
\-\ described\\:\\ 0\\.00197255755631039\ \(0\)\
\-\ function\\:\\ 0\\.0019634480070874188\ \(0\)\
\-\ characteristic\\:\\ 0\\.0019604451992957577\ \(0\)\
\-\ and\\/or\\:\\ 0\\.001957458935983579\ \(0\)\
\-\ ed\\:\\ 0\\.001957458935983579\ \(0\)\
\-\ recurrent\\:\\ 0\\.0019544890358401505\ \(0\)\
\-\ diameter\\:\\ 0\\.0019485976145735358\ \(0\)\
\-\ motor\\:\\ 0\\.0019341432801116597\ \(0\)\
\-\ administration\\:\\ 0\\.001922851092088439\ \(0\)\
\-\ an\\:\\ 0\\.0019214062833898045\ \(0\)\
\-\ done\\:\\ 0\\.0019200644256925482\ \(0\)\
\-\ foot\\:\\ 0\\.0019145337101509538\ \(0\)\
\-\ specific\\:\\ 0\\.0019145337101509538\ \(0\)\
\-\ limits\\:\\ 0\\.001909058861377781\ \(0\)\
\-\ prominent\\:\\ 0\\.0019009489032874218\ \(0\)\
\-\ upon\\:\\ 0\\.0018929585066818915\ \(0\)\
\-\ \\.\\:\\ 0\\.001866371274494628\ \(0\)\
\-\ range\\:\\ 0\\.0018646287351123756\ \(0\)\
\-\ motion\\:\\ 0\\.0018621252414233271\ \(0\)\
\-\ persistent\\:\\ 0\\.0018473423590820485\ \(0\)\
\-\ made\\:\\ 0\\.001844917274857159\ \(0\)\
\-\ symptomatic\\:\\ 0\\.0018400994171784348\ \(0\)\
\-\ diagnostic\\:\\ 0\\.0018353240081366163\ \(0\)\
\-\ worsening\\:\\ 0\\.0018235663796210286\ \(0\)\
\-\ system\\:\\ 0\\.0018235663796210286\ \(0\)\
\-\ 4\\.\\:\\ 0\\.0018235663796210286\ \(0\)\
\-\ pressure\\:\\ 0\\.0018189338264619727\ \(0\)\
\-\ similar\\:\\ 0\\.0018166323137890994\ \(0\)\
\-\ unknown\\:\\ 0\\.0018075227645661283\ \(0\)\
\-\ \\?\\:\\ 0\\.0018075227645661283\ \(0\)\
\-\ rate\\:\\ 0\\.0018052691005289122\ \(0\)\
\-\ about\\:\\ 0\\.0017853970222787272\ \(0\)\
\-\ second\\:\\ 0\\.0017789316722162482\ \(0\)\
\-\ skin\\:\\ 0\\.0017789316722162482\ \(0\)\
\-\ headaches\\:\\ 0\\.0017704294520711535\ \(0\)\
\-\ cord\\:\\ 0\\.0017599858646099736\ \(0\)\
\-\ http\\:\\ 0\\.0017538149582548921\ \(0\)\
\-\ referred\\:\\ 0\\.0017477135194881525\ \(0\)\
\-\ confirmed\\:\\ 0\\.0017416800016730608\ \(0\)\
\-\ greater\\:\\ 0\\.0017396836626940384\ \(0\)\
\-\ has\\:\\ 0\\.0017395121631374286\ \(0\)\
\-\ 8\\:\\ 0\\.0017317710342814895\ \(0\)\
\-\ ago\\:\\ 0\\.0017239722605947147\ \(0\)\
\-\ abnormality\\:\\ 0\\.0017087034925910851\ \(0\)\
\-\ intact\\:\\ 0\\.0017012274372348057\ \(0\)\
\-\ above\\:\\ 0\\.0016975277271695482\ \(0\)\
\-\ risk\\:\\ 0\\.0016776187790564154\ \(0\)\
\-\ they\\:\\ 0\\.001668805488611006\ \(0\)\
\-\ otherwise\\:\\ 0\\.0016635854923720027\ \(0\)\
\-\ would\\:\\ 0\\.0016482205303100757\ \(0\)\
\-\ \\&\\:\\ 0\\.0016267685052257083\ \(0\)\
\-\ involving\\:\\ 0\\.0016251529886196713\ \(0\)\
\-\ side\\:\\ 0\\.0016045780497366238\ \(0\)\
\-\ given\\:\\ 0\\.001587758478328641\ \(0\)\
\-\ does\\:\\ 0\\.0015802824229723613\ \(0\)\
\-\ week\\:\\ 0\\.0015729080858147577\ \(0\)\
\-\ cause\\:\\ 0\\.0015670800143913095\ \(0\)\
\-\ fever\\:\\ 0\\.0015670800143913095\ \(0\)\
\-\ possible\\:\\ 0\\.0015598819614547816\ \(0\)\
\-\ recent\\:\\ 0\\.0015570292947641178\ \(0\)\
\-\ first\\:\\ 0\\.0015541915635695677\ \(0\)\
\-\ palpation\\:\\ 0\\.0015457664392130362\ \(0\)\
\-\ space\\:\\ 0\\.0015320092179277151\ \(0\)\
\-\ radiation\\:\\ 0\\.0015199193764565508\ \(0\)\
\-\ positive\\:\\ 0\\.0015029190191241826\ \(0\)\
\-\ medial\\:\\ 0\\.001481463150997318\ \(0\)\
\-\ follow\\:\\ 0\\.0014716528303232706\ \(0\)\
\-\ post\\:\\ 0\\.0014584471723969072\ \(0\)\
\-\ aspect\\:\\ 0\\.0014549007774977546\ \(0\)\
\-\ medical\\:\\ 0\\.0014251001626374006\ \(0\)\
\-\ severe\\:\\ 0\\.0014251001626374006\ \(0\)\
\-\ fat\\:\\ 0\\.0014086245652474977\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.0013842963358511955\ \(0\)\
\-\ 6\\:\\ 0\\.0013832629600947829\ \(0\)\
\-\ negative\\:\\ 0\\.0013832629600947829\ \(0\)\
\-\ there\\:\\ 0\\.0013785534487425351\ \(0\)\
\-\ not\\:\\ 0\\.0013385568257365153\ \(0\)\
\-\ his\\:\\ 0\\.0013348992019766568\ \(0\)\
\-\ through\\:\\ 0\\.001315423858222693\ \(0\)\
\-\ following\\:\\ 0\\.001314513689377316\ \(0\)\
\-\ likely\\:\\ 0\\.0013063902254393802\ \(0\)\
\-\ include\\:\\ 0\\.0012992701832142475\ \(0\)\
\-\ 4\\:\\ 0\\.0012904996776038186\ \(0\)\
\-\ however\\:\\ 0\\.0012896303824374365\ \(0\)\
\-\ history\\:\\ 0\\.0012793653525280037\ \(0\)\
\-\ high\\:\\ 0\\.0012675046401500357\ \(0\)\
\-\ trauma\\:\\ 0\\.0012666714264270619\ \(0\)\
\-\ significant\\:\\ 0\\.0012454456103274923\ \(0\)\
\-\ up\\:\\ 0\\.0012454456103274923\ \(0\)\
\-\ lesions\\:\\ 0\\.001239870193140351\ \(0\)\
\-\ due\\:\\ 0\\.0012359225761262003\ \(0\)\
\-\ mild\\:\\ 0\\.0012196495685263616\ \(0\)\
\-\ than\\:\\ 0\\.0012135766151318557\ \(0\)\
\-\ who\\:\\ 0\\.001207570953464337\ \(0\)\
\-\ these\\:\\ 0\\.0012053358763999132\ \(0\)\
\-\ over\\:\\ 0\\.0011792100759566192\ \(0\)\
\-\ acute\\:\\ 0\\.0011435660320360409\ \(0\)\
\-\ surgery\\:\\ 0\\.001124660739490664\ \(0\)\
\-\ noted\\:\\ 0\\.001097789262033926\ \(0\)\
\-\ imaging\\:\\ 0\\.0010851348642035787\ \(0\)\
\-\ woman\\:\\ 0\\.001069866096199949\ \(0\)\
\-\ most\\:\\ 0\\.0010692873396900141\ \(0\)\
\-\ other\\:\\ 0\\.0010675547689444167\ \(0\)\
\-\ present\\:\\ 0\\.0010460752053830249\ \(0\)\
\-\ it\\:\\ 0\\.0010411102355192502\ \(0\)\
\-\ \\'s\\:\\ 0\\.0010211634787897262\ \(0\)\
\-\ exam\\:\\ 0\\.0010174709701623512\ \(0\)\
\-\ may\\:\\ 0\\.0010158961349041322\ \(0\)\
\-\ case\\:\\ 0\\.001013281535429415\ \(0\)\
\-\ findings\\:\\ 0\\.000985819477392932\ \(0\)\
\-\ after\\:\\ 0\\.0009582662344765325\ \(0\)\
\-\ treatment\\:\\ 0\\.000937461766721348\ \(0\)\
\-\ seen\\:\\ 0\\.0009152453198198863\ \(0\)\
\-\ within\\:\\ 0\\.0008835400587458437\ \(0\)\
\-\ which\\:\\ 0\\.000864577012055582\ \(0\)\
\-\ disease\\:\\ 0\\.0007570393177320889\ \(0\)\
\-\ with\\:\\ 0\\.0006975858737066597\ \(0\)\
\-\ this\\:\\ 0\\.0005209415790320504\ \(0\)\
\-\ year\\:\\ 0\\.0005182142380883006\ \(0\)\
